v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 2,362
Cost of goods sold 2,178
Gross profit 184
Operating expenses:    
Research and development 6,417 5,419
Selling, general and administrative 9,939 4,363
Total operating expenses 16,356 9,782
Loss from operations (16,172) (9,782)
Other (expense) income:    
Interest expense (1,316) (1,397)
Interest income 414 633
(Loss) on foreign currency (8)
Total other (expense), net (902) (772)
Loss before income taxes (17,074) (10,554)
Income tax expense
Net loss $ (17,074) $ (10,554)
 Net loss per share attributable to common stockholders:    
Net loss per share attributable to common stockholders, basic $ (0.38) $ (0.28)
Net loss per share attributable to common stockholders, diluted $ (0.38) $ (0.28)
Weighted-average number of common shares outstanding:    
Weighted-average number of common shares outstanding, basic 45,038,351 37,254,117
Weighted-average number of common shares outstanding, diluted 45,038,351 37,254,117